Mason Marks is a professor at the Florida State University College of Law and the senior fellow and project lead of the Project on Psychedelics Law and Regulation at the Petrie–Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Marks and I.G. Cohen. How Should the FDA Evaluate Psychedelic Medicine? N Engl J Med 2023;389:1733-1735.
